XML 29 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note K - Stockholders' Equity
 12 Months Ended
Dec. 31, 2017
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
 
NOTE K — STOCKHOLDERS’ EQUITY
 
ISSUANCES COMMON STOCK
 
In
June 2016,
Milestone Scientific raised an additional
$2.0
million of gross proceeds in a private placement of
one million
shares of common stock, at a price of
$2.00
per share, to the same investors that participated in the 
May 2014
Financing.
 
In
July 2016,
Milestone Scientific raised gross proceeds of
$250,000
in a registered direct offering of
104,200
shares of common stock at
$2.40
per share. The transaction was covered by the prospectus supplement, filed with the United States Securities and Exchange Commission ("SEC) on
July 22, 2016,
to our shelf registration statement on Form S-
3
(SEC File
No.:
333
-
209466
). 
 
          
In
December 2016,
Milestone Scientific completed an underwritten public offering of
2,000,000
shares of common stock and warrants to purchase up to
1,592,775
shares of common stock, including
92,775
additional warrants pursuant to a partial exercise of the over-allotment option granted to the underwriters. Each share of common stock was sold in combination with a warrant to purchase
0.75
shares of common stock. The public offering price for each share and related
.75
share warrant was
$1.50
for gross proceeds of
$3,000,000.
The warrants have a
three
-year term and an exercise price of
$2.55
per share.  In
January 2017,
the underwriter exercised a portion of its over-allotment option to purchase an additional
123,700
shares of common stock at the public offering price of
$1.499
per share for gross proceeds of approximately
$186,000.
The gross proceeds from this offering, including proceeds from partial exercises of the over-allotment option, were approximately
$3,200,000,
before deducting underwriting discounts and commissions and other offering expenses of
$4461,493.
  
  
 
In
January 2017,
the underwriter exercised a portion of its over-allotment option and purchased an additional
123,700
shares of common stock at the public offering price of
$1.499
per share. The gross proceeds were approximately
$186,000
before deducting underwriting discounts and commissions and other offering expenses.
 
 PREFERRED STOCK
 
 
 
        In
May
of
2014,
Milestone completed a private placement, which raised gross proceeds in the total of
$10
million, from the sale of
$3
million of Milestone Scientific common stock (
two million
shares at
$1.50
per share) and
$7
million of our Series A Convertible Preferred Stock ("preferred stock") (
7,000
shares at
$1,000
per share), convertible into common stock at
$2.37
per share (as adjusted to date) on
May 14, 2019,
or
$1.50
per share unless certain conditions are
not
met both subject to anti-dilution adjustment. The conversion ratio adjustment becomes effective if anyone of a number of triggering events occur such as; issuance of stock dividends or distributions, subdivisions, splits, issuance of stock purchase rights, debt and distributions, cash dividends or distributions, self-tender offers and exchange offers, rights plans and issuances below the conversion price, as defined in the Investment Agreement. Generally, each share of preferred stock entitles the holder to vote together with the holders of Milestone Scientific common stock, as a single class, on all matters submitted for the approval of the holders of Milestone Scientific common stock and has the number of votes equal to the number of shares of our common stock into which they are then convertible.  In addition, preferred stock is also entitled to share, pair pass, in any cash dividends declared on Milestone Scientific common stock on as converted basis.
 
SH
ARES TO BE ISSUED
 
 
       
As of
December 31, 2017,
and
2016,
there were
1,401,247
and
1,270,481
shares, respectively, whose issuance has been deferred under the terms of an employment agreements with the Chief Executive Officer, Chief Financial Officer and other employees of Milestone Scientific. Such shares will be issued to each party upon termination of their employment. The number of shares was fixed at the date of grant and were fully vested upon grant date.
 
SHARES RESERVED FOR FUTURE ISSUANCE
 
 
        At
December 31, 2017
and
2016
there were
5,111,582
 and
4,600,250
shares reserved for future issuance and
3,710,335
 and
3,329,769
shares underlying other stock options and warrants outstanding, respectively. At
December 31, 2017
and
2016
there were
1,401,247
shares and
1,270,481
shares, respectively, reserved for issuance in settlement of deferred compensation to officers of Milestone Scientific.